Press release from PR Newswire
Hologic to Host Investor Presentation at RSNA 2011
Thursday, October 27, 2011
Hologic to Host Investor Presentation at RSNA 201114:00 EDT Thursday, October 27, 2011BEDFORD, Mass., Oct. 27, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the Company will host presentations for members of the investment community at the 2011 RSNA (Radiological Society of North America) trade show in Chicago, IL. For more information about RSNA, please visit http://rsna2011.rsna.org/.Hologic's investor meeting will be held on Tuesday, November 29, 2011, at McCormick Place from 8:00 to 10:00 a.m. (Central Time) and will include presentations by members of Hologic's management team.Interested participants may listen to the call (listen mode only) by dialing 800-901-5217 or 617-786-2964, passcode 30702304 and referencing the Hologic Investor Meeting. For those unable to participate in the live broadcast, a replay will be available two hours after the call ends through Friday, December 16, 2011 at 888-286-8010 or 617-801-6888, passcode 64020249. Interested participants are also invited to listen to a live audio webcast of Hologic's presentation on the investor relations page of the Company's website at www.hologic.com/investor-overview. An archive of the presentation will be available for replay following the event. About Hologic, Inc.Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, breast Magnetic Resonance Imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.Contact:Deborah GordonVice President, Investor RelationsHologic, Inc.(781) 999-7716SOURCE Hologic, Inc.